Patent ID: 11958911
Assignee: SHANGHAI BENEMAE PHARMACEUTICAL
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 2:
3. An isolated anti-FXI or anti-FXIa antibody that specifically binds to human FXI or FXIa or immunologically active portion thereof, wherein the antibody comprises a pair of sequences selected from the group consisting of SEQ ID NOs: 9-10, SEQ ID NOs: 25-26, SEQ ID NOs: 41-42, SEQ ID NOs: 57-58, SEQ ID NOs: 73-74, SEQ ID NOs: 89-90, SEQ ID NOs: 105-106, SEQ ID NOs: 121-122, SEQ ID NOs: 137-138, SEQ ID NOs: 153-154, SEQ ID NOs: 169-170, SEQ ID NOs: 185-186, SEQ ID NOs; 197-198, SEQ ID NOs: 199-200, SEQ ID NOs: 201-202, SEQ ID NOs: 204-205, SEQ ID NOs: 206-207, and SEQ ID NOs: 208-209.